These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 411847)

  • 81. [Studies of sustained release cephalexin (S-6437) in pediatrics (author's transl)].
    Saito K; Ubukata K; Konno M
    Jpn J Antibiot; 1977 Sep; 30(9):672-6. PubMed ID: 916187
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Clinical investigation of cefadroxil in pediatric field (author's transl)].
    Nanri S; Jozaki K; Hattori H; Hotta M; Akita H; Yamashita N; Sunakawa K; Oikawa T; Ichihashi Y; Takahashi H; Iwata S; Kori T
    Jpn J Antibiot; 1981 Feb; 34(2):152-6. PubMed ID: 7253194
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In vitro susceptibility of gram-negative bacilli to carbenicillin.
    Washington JA
    Mayo Clin Proc; 1972 May; 47(5):332-4. PubMed ID: 4555345
    [No Abstract]   [Full Text] [Related]  

  • 84. [Laboratory and clinical studies on amikacin (BB-K8), a new semisynthetic aminoglycoside (author's transl)].
    Isogai K; Shimizu Y; Kawada Y; Nishiura T
    Jpn J Antibiot; 1974 Jun; 27(3):328-36. PubMed ID: 4140246
    [No Abstract]   [Full Text] [Related]  

  • 85. [Laboratory and clinical evaluation of Cefazolin].
    Kiriyama T; Takara M; Hayashida S; Sakatoku J
    Hinyokika Kiyo; 1971 Dec; 17(12):775-80. PubMed ID: 5004290
    [No Abstract]   [Full Text] [Related]  

  • 86. Kanamycin in urinary tract infections.
    Petersdorf RG; Turck M
    Ann N Y Acad Sci; 1966 Jun; 132(2):834-41. PubMed ID: 4960374
    [No Abstract]   [Full Text] [Related]  

  • 87. Comparative study of Minocycline and Ampicillin in the treatment of urinary tract infections.
    Klastersky J; Daneau D
    Int J Clin Pharmacol; 1974 Mar; 9(2):125-31. PubMed ID: 4208030
    [No Abstract]   [Full Text] [Related]  

  • 88. [Clinical evaluation of long-acting preparation of cephalexin (S-6436) in the treatment of acute tonsillitis and acute otitis media--a double blind study (author's transl)].
    Baba S; Ito H; Tsukiyama M; Iwata S; Nishimura T
    Kansenshogaku Zasshi; 1977 Jun; 51(6):286-302. PubMed ID: 411841
    [No Abstract]   [Full Text] [Related]  

  • 89. [The effect of gentamicin and other antibiotics on the pathogenic germs in urinary tract infections (author's transl)].
    Schmid W
    Med Klin; 1973 Dec; 68(50):1652-6. PubMed ID: 4205807
    [No Abstract]   [Full Text] [Related]  

  • 90. [Effective treatment of urinary tract infection with carbenicillin].
    Yamamoto C; Miyoshi T; Namikawa K; Fukuchi S
    Hinyokika Kiyo; 1971 Sep; 17(9):596-600. PubMed ID: 5001081
    [No Abstract]   [Full Text] [Related]  

  • 91. [Laboratory and clinical investigation of amikacin (BB-K8) (author's transl)].
    Kato Y; Saito A; Ishikawa K; Nakayama I; Tomizawa M
    Jpn J Antibiot; 1974 Jun; 27(3):343-7. PubMed ID: 4215898
    [No Abstract]   [Full Text] [Related]  

  • 92. [Evaluation of amikacin in obstetric and gynecological fields (author's transl)].
    Matsuda S; Mori S; Tanno M; Kashiwagura T
    Jpn J Antibiot; 1974 Oct; 27(5):633-6. PubMed ID: 4617009
    [No Abstract]   [Full Text] [Related]  

  • 93. A clinical study of cephalexin.
    Roberts LN
    J Clin Pharmacol; 1973 Jul; 13(7):276-82. PubMed ID: 4488997
    [No Abstract]   [Full Text] [Related]  

  • 94. Prophylactic long-term cephalexin in recurrent urinary infection.
    Fairley KF; Hubbard M; Whitworth JA
    Med J Aust; 1974 Mar; 1(9):318-9. PubMed ID: 4824002
    [No Abstract]   [Full Text] [Related]  

  • 95. [Pili-mediated agglutination of Serratia marcescens in human urine (author's transl)].
    Ohshima H; Amako K
    Kansenshogaku Zasshi; 1981 Jan; 55(1):25-31. PubMed ID: 6114121
    [No Abstract]   [Full Text] [Related]  

  • 96. [Pharmacological and clinical studies on S-6436 in urinary tract infections (author's transl)].
    Ishigami J; Tanikaze S; Kataoka N; Yamaguchi K; Mita T
    Kansenshogaku Zasshi; 1977 Jun; 51(6):335-42. PubMed ID: 411847
    [No Abstract]   [Full Text] [Related]  

  • 97. [Clinical and pharmacological evaluation of S-6436 (long acting preparation of cephalexin) in urinary tract infections (author's transl)].
    Takamoto H; Kamata H; Hirano M; Niijima T; Onoda T
    Kansenshogaku Zasshi; 1977 Jun; 51(6):343-52. PubMed ID: 411848
    [No Abstract]   [Full Text] [Related]  

  • 98. [Clinical experience with S-6436 in patients with urinary tract infections (author's transl)].
    Urata H; Komeda K; Tochigi H; Morishita F; Horiuchi E
    Jpn J Antibiot; 1977 Oct; 30(10):829-34. PubMed ID: 338939
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Clinical studies on S-6436 in urinary tract infections (author's transl)].
    Onodera S; Machida T; Ohishi Y; Okazaki T; Teramoto K
    Kansenshogaku Zasshi; 1977 Jun; 51(6):321-6. PubMed ID: 411845
    [No Abstract]   [Full Text] [Related]  

  • 100. [Clinical and bacteriological studies on the course of 31 cases of most severe chronic urinary tract infections during mainly discordant cephalexin medication].
    Breitfellner G; Gasser G; Hauke D
    Schweiz Rundsch Med Prax; 1973 Mar; 62(12):366-78. PubMed ID: 4570646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.